Leif Bergsagel
- Molecular Biology
- Hematology top 5%
- Oncology
- Immunology
- Genetics top 10%
- Co-authors
- Andrea CeruttiHong ZanAndrás SchafferNagaradona HarindranathEdward E. MaxPaolo CasaliAngela DispenzieriMorie A. Gertz
- Topics
- Multiple Myeloma Research and Treatments (25 papers)Protein Degradation and Inhibitors (13 papers)PI3K/AKT/mTOR signaling in cancer (5 papers)
- Cited by
- HematologyGeneticsImmunology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Leif Bergsagel
38 papers receiving 666 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 365
- Hematology 330
- Oncology 215
- Immunology 188
- Genetics 132
Countries citing papers authored by Leif Bergsagel
This map shows the geographic impact of Leif Bergsagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leif Bergsagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leif Bergsagel more than expected).
Fields of papers citing papers by Leif Bergsagel
This network shows the impact of papers produced by Leif Bergsagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leif Bergsagel. The network helps show where Leif Bergsagel may publish in the future.
Co-authorship network of co-authors of Leif Bergsagel
This figure shows the co-authorship network connecting the top 25 collaborators of Leif Bergsagel. A scholar is included among the top collaborators of Leif Bergsagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leif Bergsagel. Leif Bergsagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 35 | |
| 5 | 1 | |
| 6 | 17 | |
| 7 | 8 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | 102 | |
| 17 | 7 | |
| 18 | 9 | |
| 19 | 1 | |
| 20 | 181 |
About Leif Bergsagel
Leif Bergsagel is a scholar working on Hematology, Genetics and Molecular Biology, having authored 38 papers that have together received 673 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (25 papers), Protein Degradation and Inhibitors (13 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Hematology (330 citations), Genetics (132 citations) and Immunology (188 citations). Leif Bergsagel has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrea Cerutti, Hong Zan, András Schaffer, Nagaradona Harindranath, Edward E. Max, Paolo Casali, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy and Suzanne R. Hayman. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.